Evidence for noradrenergic involvement in episodic prolactin and growth hormone release in ovariectomized rats

A. Negro-Vilar, Sergio Ojeda, J. P. Advis, S. M. McCann

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Episodic release of PRL and GH was studied in conscious ovariectomized (OVX) rats. Three to 5 weeks after OVX, animals bearing indwelling jugular cannulae were bled at 10-min intervals for 2 h, usually between 1100-1500 h. All animals showed frequent secretory bursts of PRL and GH. PRL levels varied from trough values of 5-10 ng/ml to peak concentrations ranging from 20-65 ng/ml. GH levels fluctuated from baseline values of around 15 ng/ml to peak levels higher than 40 ng/ml in all animals studied (range, 45-205 ng/ml). In another group of animals, norepinephrine (NE) synthesis was inhibited by administering diethyldithiocarbamate (DDC), an inhibitor of dopamine-β-hydroxylase, 2 h before the bleeding period. After this treatment, complete suppression of both PRL and GH secretory episodes was observed. Effectiveness of the DDC treatment was ascertained by measuring the content of NE and dopamine in the median eminence, medial basal hypothalamus, and suprachiasmatic-preoptic area by radioenzymatic assay. At 4 h after DDC injection, NE levels in all three areas were significantly reduced, whereas dopamine levels were not affected. Stimulation of α-adrenergic receptors with clonidine in DDC-treated rats induced a small rise in PRL levels and a distinct rise in GH. If the OVX rats were pretreated with estradiol benzoate (20 μg/rat, 48 h before the experiment), the effect of clonidine on PRL release was remarkably potentiated, while the GH response was somewhat diminished. These results indicate that the noradrenergic system plays an important stimulatory role in episodic PRL and GH secretion and also that the actions of NE on PRL and GH secretion may be differentially modulated by estrogens.

Original languageEnglish (US)
Pages (from-to)86-91
Number of pages6
JournalEndocrinology
Volume105
Issue number1
StatePublished - 1979
Externally publishedYes

Fingerprint

Ditiocarb
Prolactin
Growth Hormone
Norepinephrine
Dopamine
Clonidine
Middle Hypothalamus
Median Eminence
Preoptic Area
Mixed Function Oxygenases
Adrenergic Receptors
Estrogens
Neck
Hemorrhage
Injections

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Evidence for noradrenergic involvement in episodic prolactin and growth hormone release in ovariectomized rats. / Negro-Vilar, A.; Ojeda, Sergio; Advis, J. P.; McCann, S. M.

In: Endocrinology, Vol. 105, No. 1, 1979, p. 86-91.

Research output: Contribution to journalArticle

@article{785385e5bf314dcbba106713c389ee28,
title = "Evidence for noradrenergic involvement in episodic prolactin and growth hormone release in ovariectomized rats",
abstract = "Episodic release of PRL and GH was studied in conscious ovariectomized (OVX) rats. Three to 5 weeks after OVX, animals bearing indwelling jugular cannulae were bled at 10-min intervals for 2 h, usually between 1100-1500 h. All animals showed frequent secretory bursts of PRL and GH. PRL levels varied from trough values of 5-10 ng/ml to peak concentrations ranging from 20-65 ng/ml. GH levels fluctuated from baseline values of around 15 ng/ml to peak levels higher than 40 ng/ml in all animals studied (range, 45-205 ng/ml). In another group of animals, norepinephrine (NE) synthesis was inhibited by administering diethyldithiocarbamate (DDC), an inhibitor of dopamine-β-hydroxylase, 2 h before the bleeding period. After this treatment, complete suppression of both PRL and GH secretory episodes was observed. Effectiveness of the DDC treatment was ascertained by measuring the content of NE and dopamine in the median eminence, medial basal hypothalamus, and suprachiasmatic-preoptic area by radioenzymatic assay. At 4 h after DDC injection, NE levels in all three areas were significantly reduced, whereas dopamine levels were not affected. Stimulation of α-adrenergic receptors with clonidine in DDC-treated rats induced a small rise in PRL levels and a distinct rise in GH. If the OVX rats were pretreated with estradiol benzoate (20 μg/rat, 48 h before the experiment), the effect of clonidine on PRL release was remarkably potentiated, while the GH response was somewhat diminished. These results indicate that the noradrenergic system plays an important stimulatory role in episodic PRL and GH secretion and also that the actions of NE on PRL and GH secretion may be differentially modulated by estrogens.",
author = "A. Negro-Vilar and Sergio Ojeda and Advis, {J. P.} and McCann, {S. M.}",
year = "1979",
language = "English (US)",
volume = "105",
pages = "86--91",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "1",

}

TY - JOUR

T1 - Evidence for noradrenergic involvement in episodic prolactin and growth hormone release in ovariectomized rats

AU - Negro-Vilar, A.

AU - Ojeda, Sergio

AU - Advis, J. P.

AU - McCann, S. M.

PY - 1979

Y1 - 1979

N2 - Episodic release of PRL and GH was studied in conscious ovariectomized (OVX) rats. Three to 5 weeks after OVX, animals bearing indwelling jugular cannulae were bled at 10-min intervals for 2 h, usually between 1100-1500 h. All animals showed frequent secretory bursts of PRL and GH. PRL levels varied from trough values of 5-10 ng/ml to peak concentrations ranging from 20-65 ng/ml. GH levels fluctuated from baseline values of around 15 ng/ml to peak levels higher than 40 ng/ml in all animals studied (range, 45-205 ng/ml). In another group of animals, norepinephrine (NE) synthesis was inhibited by administering diethyldithiocarbamate (DDC), an inhibitor of dopamine-β-hydroxylase, 2 h before the bleeding period. After this treatment, complete suppression of both PRL and GH secretory episodes was observed. Effectiveness of the DDC treatment was ascertained by measuring the content of NE and dopamine in the median eminence, medial basal hypothalamus, and suprachiasmatic-preoptic area by radioenzymatic assay. At 4 h after DDC injection, NE levels in all three areas were significantly reduced, whereas dopamine levels were not affected. Stimulation of α-adrenergic receptors with clonidine in DDC-treated rats induced a small rise in PRL levels and a distinct rise in GH. If the OVX rats were pretreated with estradiol benzoate (20 μg/rat, 48 h before the experiment), the effect of clonidine on PRL release was remarkably potentiated, while the GH response was somewhat diminished. These results indicate that the noradrenergic system plays an important stimulatory role in episodic PRL and GH secretion and also that the actions of NE on PRL and GH secretion may be differentially modulated by estrogens.

AB - Episodic release of PRL and GH was studied in conscious ovariectomized (OVX) rats. Three to 5 weeks after OVX, animals bearing indwelling jugular cannulae were bled at 10-min intervals for 2 h, usually between 1100-1500 h. All animals showed frequent secretory bursts of PRL and GH. PRL levels varied from trough values of 5-10 ng/ml to peak concentrations ranging from 20-65 ng/ml. GH levels fluctuated from baseline values of around 15 ng/ml to peak levels higher than 40 ng/ml in all animals studied (range, 45-205 ng/ml). In another group of animals, norepinephrine (NE) synthesis was inhibited by administering diethyldithiocarbamate (DDC), an inhibitor of dopamine-β-hydroxylase, 2 h before the bleeding period. After this treatment, complete suppression of both PRL and GH secretory episodes was observed. Effectiveness of the DDC treatment was ascertained by measuring the content of NE and dopamine in the median eminence, medial basal hypothalamus, and suprachiasmatic-preoptic area by radioenzymatic assay. At 4 h after DDC injection, NE levels in all three areas were significantly reduced, whereas dopamine levels were not affected. Stimulation of α-adrenergic receptors with clonidine in DDC-treated rats induced a small rise in PRL levels and a distinct rise in GH. If the OVX rats were pretreated with estradiol benzoate (20 μg/rat, 48 h before the experiment), the effect of clonidine on PRL release was remarkably potentiated, while the GH response was somewhat diminished. These results indicate that the noradrenergic system plays an important stimulatory role in episodic PRL and GH secretion and also that the actions of NE on PRL and GH secretion may be differentially modulated by estrogens.

UR - http://www.scopus.com/inward/record.url?scp=0018766092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018766092&partnerID=8YFLogxK

M3 - Article

VL - 105

SP - 86

EP - 91

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 1

ER -